Literature DB >> 21764232

Epilepsy in children with methylmalonic acidemia: electroclinical features and prognosis.

Xiuwei Ma1, Yuehua Zhang, Yanling Yang, Xiaoyan Liu, Zhixian Yang, Xinhua Bao, Jiong Qin, Xiru Wu.   

Abstract

OBJECTIVE: To summarize the electroclinical features and prognosis of epilepsy in children with methylmalonic acidemia (MMA).
METHODS: The medical records of hospitalized MMA patients associated with epilepsy were retrospectively reviewed. The clinical manifestations, laboratory examination results, and treatment modalities were analyzed.
RESULTS: From 63 pediatric inpatients diagnosed as MMA in Peking University First Hospital from June 1996 to December 2009, 27 children (42.9%) associated with epilepsy were enrolled in this study. These 27 patients were also accompanied with other neurological manifestations including mental retardation or regression (n=22), lethargy (n=10), increased muscle tone (n=8), muscle hypotonia (n=8), recurrent vomiting (n=4), tremor (n=2), ataxia (n=2), and abnormal posture (n=1).The onset age of seizure ranged from 8 days to 11 years. The seizure types included partial seizure (n=21), generalized tonic-clonic seizure (n=5), tonic seizure (n=3), myoclonic seizure (n=3), and epileptic spasms (n=2). Five patients had two or three seizure types. Nine patients (33.3%) had a history of status epilepticus. EEG showed slow background activity in 17 patients, focal or multifocal paroxysmal discharges in 16 patients, generalized paroxysmal discharges in four patients, hypsarrythmia in two patients, and suppression-burst pattern in one patient. Cranial MRI scans showed bilateral cerebral atrophy (n=14), increased T2 signal intensities in white matter (n=12), agenesis of corpus callosum (n=2), bilateral increased T2 signal intensities or necrosis in basal ganglia (n=2), and cerebellar atrophy (n=1). Twenty one patients were MMA combined with homocysteinemia. Seventeen patients were confirmed with cobalamin C disease and one with partial mutase deficiency (mut(-)). Vitamin B12-responsive patients had a better outcome compared with vitamin B12-unresponsive patients.
CONCLUSIONS: Epilepsy is a common manifestation of patients with MMA. Partial seizure is more common than other seizure types. Urine organic acid analysis should be performed for children with unknown cause of epilepsy combined with other neurological manifestations, so as to promptly identify the etiology and improve the prognosis.
Copyright © 2011 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21764232     DOI: 10.1016/j.braindev.2011.06.001

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  8 in total

1.  Epileptic syndrome with myoclonus as manifestation of adult-onset CblC deficiency.

Authors:  Roberta Di Giacomo; Ettore Salsano; Francesco Deleo; Chiara Pastori; Giuseppe Didato; Andrea Stabile; Rosalba Ferrario; Anna Rita Giovagnoli; Chiara Benzoni; Lidia Sarro; Elisa Visani; Laura Canafoglia
Journal:  J Neurol       Date:  2022-04-11       Impact factor: 6.682

2.  Clinical characteristics of hemolytic uremic syndrome secondary to cobalamin C disorder in Chinese children.

Authors:  Qi-Liang Li; Wen-Qi Song; Xiao-Xia Peng; Xiao-Rong Liu; Le-Jian He; Li-Bing Fu
Journal:  World J Pediatr       Date:  2015-08-08       Impact factor: 2.764

3.  Guidelines for the diagnosis and management of methylmalonic acidaemia and propionic acidaemia: First revision.

Authors:  Patrick Forny; Friederike Hörster; Diana Ballhausen; Anupam Chakrapani; Kimberly A Chapman; Carlo Dionisi-Vici; Marjorie Dixon; Sarah C Grünert; Stephanie Grunewald; Goknur Haliloglu; Michel Hochuli; Tomas Honzik; Daniela Karall; Diego Martinelli; Femke Molema; Jörn Oliver Sass; Sabine Scholl-Bürgi; Galit Tal; Monique Williams; Martina Huemer; Matthias R Baumgartner
Journal:  J Inherit Metab Dis       Date:  2021-03-09       Impact factor: 4.750

4.  Hemiconvulsion-Hemiplegia-Epilepsy in a girl with cobalamin C deficiency.

Authors:  Kenneth A Myers; Roy Wr Dudley; Myriam Srour
Journal:  Epileptic Disord       Date:  2018-12-01       Impact factor: 1.819

Review 5.  The Value of Liver Transplantation for Methylmalonic Acidemia.

Authors:  Yi-Zhou Jiang; Li-Ying Sun
Journal:  Front Pediatr       Date:  2019-03-21       Impact factor: 3.418

6.  Comparing amniotic fluid mass spectrometry assays and amniocyte gene analyses for the prenatal diagnosis of methylmalonic aciduria.

Authors:  Yupeng Liu; Zhehui Chen; Lulu Kang; Ruxuan He; Jinqing Song; Yi Liu; Chunyan Shi; Junya Chen; Hui Dong; Yao Zhang; Yanyan Ma; Tongfei Wu; Qiao Wang; Yuan Ding; Xiyuan Li; Dongxiao Li; Mengqiu Li; Ying Jin; Jiong Qin; Yanling Yang
Journal:  PLoS One       Date:  2022-03-31       Impact factor: 3.240

7.  Methylmalonic acidemia: diagnosis and neuroimaging findings of this neurometabolic disorder (an Iranian pediatric case series).

Authors:  Parvaneh Karimzadeh; Narjes Jafari; Farzad Ahmad Abadi; Sayena Jabbedari; Mohammad-Mahdi Taghdiri; Hamid Nemati; Sasan Saket; Seyed-Fakhreddin Shariatmadari; Mohammad-Reza Alaee; Mohammad Ghofrani; Seyed Hasan Tonekaboni
Journal:  Iran J Child Neurol       Date:  2013

Review 8.  Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia.

Authors:  Matthias R Baumgartner; Friederike Hörster; Carlo Dionisi-Vici; Goknur Haliloglu; Daniela Karall; Kimberly A Chapman; Martina Huemer; Michel Hochuli; Murielle Assoun; Diana Ballhausen; Alberto Burlina; Brian Fowler; Sarah C Grünert; Stephanie Grünewald; Tomas Honzik; Begoña Merinero; Celia Pérez-Cerdá; Sabine Scholl-Bürgi; Flemming Skovby; Frits Wijburg; Anita MacDonald; Diego Martinelli; Jörn Oliver Sass; Vassili Valayannopoulos; Anupam Chakrapani
Journal:  Orphanet J Rare Dis       Date:  2014-09-02       Impact factor: 4.123

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.